期刊文献+

大脑中动脉M2段闭塞血管再通研究进展 被引量:2

Advances in Recanalization of M2 Segment Occlusion in Middle Cerebral Artery
下载PDF
导出
摘要 与颈内动脉和大脑中动脉M1段相比,大脑中动脉M2段更加纤细、迂曲,其急性闭塞后血管再通治疗包括静脉溶栓、动脉溶栓及机械取栓,但血管内治疗的安全性和有效性仍有争议。目前的研究显示,动脉溶栓和机械取栓的血管再通率高于单纯的静脉溶栓,但这3种治疗方法对90d预后的影响差异不大。另外,因研究相对较少,目前治疗方法对出血转化的影响尚无定论。 Compared with internal carotid artery(ICA)and middle cerebral artery(MCA)M1 segments,MCA M2 segments are more slender and tortuous.Recanalization methods for acute occlusion in MCA M2 segments include intravenous thrombolysis,arterial thrombolysis and mechanical thrombectomy.However,the safety and effectiveness of endovascular therapy still remained controversial.Current studies have shown that the recanalization rates of arterial thrombolysis and mechanical thrombectomy are higher than that of intravenous thrombolysis alone,while there is little difference in the prognosis at 90 days among the three treatment ways.In addition,due to relatively fewer studies,the impact of three treatment ways on hemorrhagic transformation remains inconclusive.
作者 刘舒鑫 李迪 LIU Shu-Xin;LI Di(Neurointerventional Department,Central Hospital of Dalian Affiliated to Dalian Medical University,Dalian 116033,China)
出处 《中国卒中杂志》 2019年第4期400-403,共4页 Chinese Journal of Stroke
关键词 大脑中动脉 静脉溶栓 动脉溶栓 机械取栓 Middle cerebral artery Intravenous thrombolysis Arterial thrombolysis Mechanical thrombectomy
  • 相关文献

参考文献3

二级参考文献38

  • 1丁宏岩,董强.基底动脉梗死的治疗:动脉和静脉溶栓效果比较的系统分析[J].中国卒中杂志,2006,1(6):414-416. 被引量:127
  • 2The National Institute of Neurological Disorders and Stroke rt- PA Stroke Study Group. Tissue plasminogen aetivator for acuteischemie stroke. N Engl J Med, 1995,333(24) : 1581-1587.
  • 3Haeke W, Kaste M, Fieschi C, et al. for the ECASS Study Group. Intravenous thromboiysis with recombinant tissue plas- minogen activator for acute hemispheric stroke: the European Cooperative Acute Stroke Study (ECASS) . JAMA, 1995, 274 (13): 1017-1025.
  • 4Hacke W, Kaste M, Fiesehi C, et al. Randomised double-blind placebo-controlled trial o[ thromholytie therapy with intravenous alteplase in acute ischaenfic stroke (ECASS II) . Lancet, 1998, 352(9136) : 1245-5121.
  • 5Clark WM, Wissman S, Albers GW, et al. Recombinant tissue type plasminogen activator (alteplase) for ischemic stroke 3 to 5 hours after symptom onset: the ATLANTIS study-a randomized controlled trial. JAMA, 1999,282(21 ) : 2019-2026.
  • 6Hacke W, Donnan G, Fieschi C, et al. Association of outcome with early stroke treatment: pooled analysis of ATLANTIS, ECASS, and NINDS rt-PA stroke trials . Lancet, 2(}04,363 (941 l ) :768 -774.
  • 7Hacke W, Kaste M, Bluhmki E, et al. Thrombolysis with Ahe- plase 3 to 4. 5 Hours after Acute Isehemic Stroke . N Engl J Med,2008,359(13) : 1317-1329.
  • 8Wahlgren N, Ahmed N, Ddvalos A , et al. Thrombolysis with al- teplase 3-4. 5 h after acute ischaemic stroke (SITS-ISTR): an observational study,2008,372(9646) : 1303-1309.
  • 9Zangerle A, Kiechl S, Spiegel M, et al. Recanalization after thrombolysis in stroke patients: predictors and prognostic impli- cations. Neurology, 2007,68(1) :39 44.
  • 10Ribo M, Alvarez-Sabin J, Montaner J, et al. Temporal profile of reeanalization after intravenous tissue plasminogen activator: se- lecting patients for rescue reperfusion techniques. Stroke,2006, 37(4) " 1000-1004.

共引文献447

同被引文献12

引证文献2

二级引证文献4

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部